Dae Hwa Pharm Co (XKRX:067080) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Dae Hwa Pharm Co FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Dae Hwa Pharm Co's Free Cash Flow for the three months ended in Mar. 2024 was ₩0 Mil. Dae Hwa Pharm Co's Revenue for the three months ended in Mar. 2024 was ₩34,694 Mil. Therefore, Dae Hwa Pharm Co's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Dae Hwa Pharm Co's current FCF Yield % is -6.33%.

The historical rank and industry rank for Dae Hwa Pharm Co's FCF Margin % or its related term are showing as below:

XKRX:067080' s FCF Margin % Range Over the Past 10 Years
Min: -18 Med: -5.25 Max: 2
Current: -7.77

During the past 13 years, the highest FCF Margin % of Dae Hwa Pharm Co was 2.00%. The lowest was -18.00%. And the median was -5.25%.

XKRX:067080's FCF Margin % is ranked worse than
67.15% of 1029 companies
in the Drug Manufacturers industry
Industry Median: 0.05 vs XKRX:067080: -7.77

Dae Hwa Pharm Co FCF Margin % Historical Data

The historical data trend for Dae Hwa Pharm Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dae Hwa Pharm Co FCF Margin % Chart

Dae Hwa Pharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-13.19

-7.07

-3.42

-18.00

-7.89

Dae Hwa Pharm Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-21.64	-5.82	-2.46	-3.13	-

Competitive Comparison of Dae Hwa Pharm Co's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Dae Hwa Pharm Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dae Hwa Pharm Co's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dae Hwa Pharm Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Dae Hwa Pharm Co's FCF Margin % falls into.

Dae Hwa Pharm Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Dae Hwa Pharm Co's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-11152.25	/	141359.215
	=	-7.89 %

Dae Hwa Pharm Co's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0	/	34693.986
	=	0.00 %

Dae Hwa Pharm Co FCF Margin % Related Terms

Thank you for viewing the detailed overview of Dae Hwa Pharm Co's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Dae Hwa Pharm Co (XKRX:067080) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Dae Hwa Pharm Co Ltd (XKRX:067080) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

495 Hanu-ro, Hoengseong-eup, Hoengseong-gun, Seoul, Gangwon-do, KOR, 225-804

Website

http://www.dhpharm.co.kr

Dae Hwa Pharm Co Ltd is a specialized pharmaceutical company. It is mainly involved in manufacturing and distribution of pharmaceutical products. The company controls approximately 70% of the domestic transdermal drug delivery system market. The company offers analgesics and anti-inflammatory drugs, antihistamines, skeletal muscle relaxants, and cardiovascular drugs. Its products are exported to Asia, South America, Africa, and the Middle East.

Dae Hwa Pharm Co (XKRX:067080) Headlines

No Headlines